Support for fast-tracking new drugs into clinical trials for childhood acute leukemia

Children's Cancer Institute, under the direction of Principal Investigator, Professor Richard Lock, Head of the Leukaemia Biology Program, has been awarded close to US$2 million for 5 years under the Pediatric Preclinical Testing Consortium (PPTC), created by NCI to prioritise and fast-track new drugs into clinical trials in children with aggressive cancers.

Read more here: http://www.eurekalert.org/pub_releases/2015-09/ccia-sff090815.php